Search

everythinglearnresearchcommunity

for

Search:↓

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Finasteride safely lowers DHT levels without affecting testosterone.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Sebocytes play a key role in controlling androgen levels in human skin.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Different skin cells process testosterone differently, and certain drugs can change this process, possibly helping treat acne and hair loss.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.